Martini, Maurizio
 Distribuzione geografica
Continente #
NA - Nord America 13.316
EU - Europa 10.392
AS - Asia 8.777
SA - Sud America 1.764
AF - Africa 252
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 20
Totale 34.544
Nazione #
US - Stati Uniti d'America 12.989
SG - Singapore 4.068
DE - Germania 3.494
CN - Cina 2.124
SE - Svezia 1.572
BR - Brasile 1.442
IT - Italia 1.113
PL - Polonia 885
VN - Vietnam 823
FR - Francia 734
UA - Ucraina 701
GB - Regno Unito 457
IE - Irlanda 418
IN - India 367
FI - Finlandia 358
ID - Indonesia 271
RU - Federazione Russa 207
JP - Giappone 189
BD - Bangladesh 167
TR - Turchia 163
CA - Canada 153
HK - Hong Kong 152
AR - Argentina 134
MX - Messico 104
IQ - Iraq 89
NL - Olanda 78
AT - Austria 68
BE - Belgio 68
ZA - Sudafrica 65
ES - Italia 56
CI - Costa d'Avorio 54
VE - Venezuela 46
EC - Ecuador 43
PK - Pakistan 37
IR - Iran 31
SA - Arabia Saudita 30
CH - Svizzera 29
CO - Colombia 28
KR - Corea 28
KE - Kenya 25
LT - Lituania 25
JO - Giordania 22
MA - Marocco 21
PH - Filippine 21
PY - Paraguay 20
UZ - Uzbekistan 20
CZ - Repubblica Ceca 19
IL - Israele 18
TN - Tunisia 18
AE - Emirati Arabi Uniti 17
CL - Cile 17
AZ - Azerbaigian 16
JM - Giamaica 16
NP - Nepal 15
PE - Perù 15
AU - Australia 14
EU - Europa 13
GR - Grecia 13
AL - Albania 12
DZ - Algeria 12
EG - Egitto 12
OM - Oman 12
RO - Romania 12
SN - Senegal 12
CR - Costa Rica 11
KZ - Kazakistan 10
PT - Portogallo 10
KG - Kirghizistan 9
UY - Uruguay 9
BG - Bulgaria 8
BO - Bolivia 8
LB - Libano 8
MD - Moldavia 8
NO - Norvegia 8
TH - Thailandia 8
BH - Bahrain 7
ET - Etiopia 7
GE - Georgia 7
HU - Ungheria 7
LV - Lettonia 7
MY - Malesia 7
TT - Trinidad e Tobago 7
TW - Taiwan 7
PA - Panama 6
HN - Honduras 5
KW - Kuwait 5
NG - Nigeria 5
NI - Nicaragua 5
PS - Palestinian Territory 5
XK - ???statistics.table.value.countryCode.XK??? 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
DO - Repubblica Dominicana 4
GA - Gabon 4
HR - Croazia 4
LK - Sri Lanka 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BW - Botswana 3
DK - Danimarca 3
Totale 34.477
Città #
Singapore 2.272
Ashburn 1.805
Chandler 1.618
San Jose 1.074
Warsaw 844
Beijing 440
Jacksonville 425
Dublin 411
San Mateo 343
Nanjing 312
Fairfield 306
New York 297
Los Angeles 296
Wilmington 290
Ann Arbor 285
Houston 280
Woodbridge 280
Ho Chi Minh City 272
Munich 245
Jakarta 241
Seattle 231
Lauterbourg 229
Hanoi 225
Nürnberg 218
Rome 193
Dearborn 190
Helsinki 178
Boston 170
The Dalles 167
Cattolica 165
Tokyo 158
Milan 150
Frankfurt am Main 149
Cambridge 146
Dallas 142
São Paulo 138
Hong Kong 136
Redmond 131
Lawrence 130
Izmir 118
Moscow 112
Nanchang 112
Council Bluffs 107
Chicago 106
Bremen 105
Hefei 101
Santa Clara 96
Marseille 94
Princeton 91
Buffalo 87
Redwood City 76
Hyderabad 75
Kunming 68
Orem 63
Paris 62
London 61
Brussels 60
Abidjan 54
Boardman 52
Mountain View 52
Tianjin 51
Phoenix 50
Brooklyn 49
Lancaster 49
Guangzhou 48
Norwalk 48
Shenyang 48
Rio de Janeiro 47
Montreal 46
Denver 45
Atlanta 43
Hebei 42
Vienna 41
Shanghai 40
Zhengzhou 40
Toronto 39
Changsha 38
Chennai 38
Johannesburg 38
Hangzhou 37
Jiaxing 37
Stockholm 35
University Park 34
Belo Horizonte 33
Düsseldorf 33
Baghdad 32
Leawood 31
Da Nang 29
Falls Church 29
Poplar 29
Haiphong 28
Amsterdam 27
Augusta 27
Jinan 26
Kent 26
Kraków 26
Naples 26
Washington 26
Seoul 25
Detroit 24
Totale 18.794
Nome #
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection 618
Diagnostic and prognostic role of HBME-1, galectin-3, and β-catenin in poorly differentiated and anaplastic thyroid carcinomas 400
Deregulated expression of the imprinted DLK1-DIO3 region in Glioblastoma Stem-like Cells: tumor suppressor role of lncRNA MEG3 393
A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes 378
Type 5 phosphodiesterase regulates glioblastoma multiforme aggressiveness and clinical outcome 349
Fanconi anemia gene variants in therapy-related myeloid neoplasms 330
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 322
Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes with Different Clinical Outcome 308
Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer? 307
BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma 306
A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor 298
Role of p16/INK4a in gastrointestinal stromal tumor progression 288
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 288
Quantification of DAPK1 Promoter Methylation in Bone Marrow and Peripheral Blood as a Follicular Lymphoma Biomarker 282
miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal 274
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 255
Glioblastoma endothelium drives bevacizumab-induced infiltrative growth via modulation of PLXDC1 254
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma 237
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 236
Defective WNT Signaling and Genetic Profile Of Endothelial Cells In Patients With Low Risk Myelodysplastic Syndromes Suggest a Contribution Of Vascular Niches To Myelodysplasia 212
A SPRY2 mutation leading to MAPK/ERK pathway inhibition is associated with an autosomal dominant form of IgA nephropathy. 211
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 211
Expression of EGFRvIII in glioblastoma: prognostic significance revisited. 210
Von hippel-lindau disease and erythrocytosis 209
Association of the OCTN1/1672T variant with increased risk for colorectal cancer in young individuals and ulcerative colitis patients 198
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia 193
Gastrointestinal stromal tumors (GISTs) and second malignancies A novel sentinel tumor? A monoinstitutional, STROBE-compliant observational analysis 193
A Large Series of Hyalinizing Trabecular Tumors: Cytomorphology and Ancillary Techniques on Fine Needle Aspiration 191
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 189
Circulating tumor DNA reveals genetics, clonal evolution and residual disease in classical Hodgkin lymphoma 187
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 187
Endoscopic ultrasound-guided fine-needle aspiration with liquid-based cytologic preparation in the diagnosis of primary pancreatic lymphoma 186
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma 186
Analysis of immunocytochemical and molecular BRAF expression in thyroid carcinomas: A cytohistologic institutional experience 186
PDGFRA-mutant syndrome 185
Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation. 184
Endothelial progenitor cells in HIV-positive patients: what are we talking about? 184
Association of the OCTN1/1672T variant with increased risk for colorectal cancer in young individuals and ulcerative colitis patients 179
Brain invasion along perivascular spaces by glioma cells: Relationship with blood–brain barrier 179
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas. 177
Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms 177
Case of Rectal GI Stromal Tumor Demonstrating that KIT and PDGFRA Mutations Are Not Always Mutually Exclusive 175
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 175
Endothelial progenitor cell dysfunction in myelodysplastic syndromes: possible contribution of a defective vascular niche to myelodysplasia 173
Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma 172
Human cord blood endothelial progenitors promote post-ischemic angiogenesis in immunocompetent mouse model. 172
Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis 171
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma. 170
Soft tissue non-Hodgkin lymphoma of shoulder in a HIV patient: a report of a case and review of the literature 167
Endoscopic ultrasound-guided fine-needle aspiration with liquid-based cytologic preparation in the diagnosis of primary pancreatic lymphoma 167
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 167
Relationship between gastric localization of hepatitis C virus and mucosa-associated lymphoid tissue in Helicobacter pylori infection 166
Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis. 166
The cytologic category of oncocytic (Hurthle) cell neoplasm mostly includes low-risk lesions at histology: an institutional experience 166
Effect of antiviral therapy on pro-angiogenic hematopoietic and endothelial progenitor cells in HIV-infected people 164
Germ Cell Neoplasia in situ (GCNIS) in Testis-Sparing Surgery (TSS) for Small Testicular Masses (STMs) 163
Diagnostic and prognostic value of immunocytochemistry and braf mutation analysis on liquid based biopsies of thyroid neoplasms suspicious for carcinoma. 162
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 162
Is surgery mandatory in locally advanced gastrointestinal stromal tumors after imatinib? A case report and literature review. 162
An abnormal secretion of soluble mediators contributes to the hematopoietic-niche dysfunction in low-risk myelodysplastic syndrome 161
DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma. 159
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma 158
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas 158
Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet. 158
Primary cerebral lymphomatoid granulomatosis: report of four cases and literature review 158
Difference in clonality as a tool for differential diagnosis of primary versus secondary lung neoplasms. 157
miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal 157
Clinical, pathological and prognostic features of rare braf mutations in metastatic colorectal cancer (Mcrc): A bi-institutional retrospective analysis (rebus study) 157
Hu/elav RNA-binding protein HuR regulates parathyroid hormone related peptide expression in human lung adenocarcinoma cells 156
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma. 155
Human cord blood endothelial progenitors promote post-ischemic angiogenesis in immunocompetent mouse model 155
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 155
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 155
Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer 152
BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma. 151
BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma. 151
Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma. 149
Endoscopic ultrasound-guided fine needle tissue acquisition biopsy samples do not allow a reliable proliferation assessment of gastrointestinal stromal tumours 149
The revised WHO diagnostic criteria for Ph-negative myeloproliferative diseases are not appropriate for the diagnostic screening of childhood polycythemia vera and essential thrombocythemia 148
DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma 148
Digital slides as an effective tool for programmed death ligand 1 combined positive score assessment and training: Lessons learned from the 'Programmed death ligand 1 key learning program in Head-and-Neck squamous cell carcinoma' 148
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 147
A novel heterozygous HIF2AM535I mutation reinforces the role of oxygen sensing pathway disturbances in the pathogenesis of familial erythrocytosis 146
Unusual focal keratin expression in plexiform angiomyxoid myofibroblastic tumor: A case report and review of the literature 146
Short Communication: Proangiogenic Hematopoietic Cells In Acute HIV Infection 145
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 145
Young investigator challenge: The morphologic analysis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on liquid-based cytology: Some insights into their identification 143
Histopathological Ratios to Predict Gleason Score Agreement between Biopsy and Radical Prostatectomy 143
Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemia 142
The role of fine-needle aspiration in the thyroid nodules of elderly patients. 142
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 142
Clinical and NGS predictors of response to regorafenib in recurrent glioblastoma 141
Class 1, 2, and 3 BRAF-mutated metastatic colorectal cancer: A detailed clinical, pathologic, and molecular characterization 141
Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities 140
Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery 140
Epigenetic alteration of SOCS family members is a possible pathogenetic mechanism in JAK2 wild type myeloproliferative diseases 140
Molecular Analysis in a Glioblastoma Cohort—Results of a Prospective Analysis 140
Expression of EGFRvIII in glioblastoma: prognostic significance revisited. 139
Methylation study of the Paris system for reporting urinary (TPS) categories 139
Endothelial progenitor cells are clonal and exhibit the JAK2(V617F) mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasms 138
Totale 19.451
Categoria #
all - tutte 137.056
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 137.056


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.128 192 164 55 174 158 79 47 327 111 140 307 374
2022/20234.514 623 649 360 712 252 543 219 349 505 57 151 94
2023/20242.435 89 591 57 130 64 247 395 287 38 77 231 229
2024/20254.256 111 124 362 182 325 172 187 183 627 438 828 717
2025/202611.560 1.671 343 661 1.343 2.122 600 2.046 607 769 724 399 275
2026/2027275 275 0 0 0 0 0 0 0 0 0 0 0
Totale 34.899